Literature DB >> 36123995

Ten decadal advances in fungal biology leading towards human well-being.

Ausana Mapook1, Kevin D Hyde1,2,3,4,5,6, Khadija Hassan7, Blondelle Matio Kemkuignou7, Adéla Čmoková8, Frank Surup7,9, Eric Kuhnert10, Pathompong Paomephan7,11, Tian Cheng7,8, Sybren de Hoog12,13,14, Yinggai Song15, Ruvishika S Jayawardena1,2, Abdullah M S Al-Hatmi12,16, Tokameh Mahmoudi17, Nadia Ponts18, Lena Studt-Reinhold19, Florence Richard-Forget18, K W Thilini Chethana1,2, Dulanjalee L Harishchandra1,2,20, Peter E Mortimer3,21, Huili Li3,21, Saisamorm Lumyong4,5,22, Worawoot Aiduang5, Jaturong Kumla4,5, Nakarin Suwannarach4,5, Chitrabhanu S Bhunjun1,2, Feng-Ming Yu1,2,23, Qi Zhao23, Doug Schaefer21, Marc Stadler7,9.   

Abstract

Fungi are an understudied resource possessing huge potential for developing products that can greatly improve human well-being. In the current paper, we highlight some important discoveries and developments in applied mycology and interdisciplinary Life Science research. These examples concern recently introduced drugs for the treatment of infections and neurological diseases; application of -OMICS techniques and genetic tools in medical mycology and the regulation of mycotoxin production; as well as some highlights of mushroom cultivaton in Asia. Examples for new diagnostic tools in medical mycology and the exploitation of new candidates for therapeutic drugs, are also given. In addition, two entries illustrating the latest developments in the use of fungi for biodegradation and fungal biomaterial production are provided. Some other areas where there have been and/or will be significant developments are also included. It is our hope that this paper will help realise the importance of fungi as a potential industrial resource and see the next two decades bring forward many new fungal and fungus-derived products.
© The Author(s) 2022.

Entities:  

Keywords:  Biomaterial; CRISPR; Drug development; Morel cultivation; Mushroom cultivation; Mycotoxin biosynthesis; Plastic degradation

Year:  2022        PMID: 36123995      PMCID: PMC9476466          DOI: 10.1007/s13225-022-00510-3

Source DB:  PubMed          Journal:  Fungal Divers        ISSN: 1560-2745            Impact factor:   24.902


  450 in total

1.  Microbial growth in a fuel-water system containing polyesterurethane foam.

Authors:  P Edmonds; J J Cooney
Journal:  Appl Microbiol       Date:  1968-02

Review 2.  Mind the mushroom: natural product biosynthetic genes and enzymes of Basidiomycota.

Authors:  Markus Gressler; Nikolai A Löhr; Tim Schäfer; Stefanie Lawrinowitz; Paula Sophie Seibold; Dirk Hoffmeister
Journal:  Nat Prod Rep       Date:  2021-04-28       Impact factor: 13.423

3.  Phylogenetic revision of Camarosporium (Pleosporineae, Dothideomycetes) and allied genera.

Authors:  D N Wanasinghe; K D Hyde; R Jeewon; P W Crous; N N Wijayawardene; E B G Jones; D J Bhat; A J L Phillips; J Z Groenewald; M C Dayarathne; C Phukhamsakda; K M Thambugala; T S Bulgakov; E Camporesi; Y S Gafforov; P E Mortimer; S C Karunarathna
Journal:  Stud Mycol       Date:  2017-08-23       Impact factor: 16.097

Review 4.  The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives.

Authors:  Andrea Huwiler; Uwe Zangemeister-Wittke
Journal:  Pharmacol Ther       Date:  2017-11-08       Impact factor: 12.310

5.  Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.

Authors:  Xiaosong Huang; Ying Wang; Wei Yan; Cory Smith; Zhaohui Ye; Jing Wang; Yongxing Gao; Laurel Mendelsohn; Linzhao Cheng
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

6.  Comparison of the hydrolysis of polyethylene terephthalate fibers by a hydrolase from Fusarium oxysporum LCH I and Fusarium solani f. sp. pisi.

Authors:  Thidarat Nimchua; Hunsa Punnapayak; Wolfgang Zimmermann
Journal:  Biotechnol J       Date:  2007-03       Impact factor: 4.677

Review 7.  Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.

Authors:  Nazem Ghasemi; Shahnaz Razavi; Elham Nikzad
Journal:  Cell J       Date:  2016-12-21       Impact factor: 2.479

9.  Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA.

Authors:  Nongnooch Poowanawittayakom; Anamika Dutta; Shannon Stock; Sunkaru Touray; Richard T Ellison; Stuart M Levitz
Journal:  Emerg Infect Dis       Date:  2018-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.